Marsh & McLennan Companies MRSH

Insurance - Brokers, Financial Services

$197.48

−0.90%

Market cap: $93.9B
PE: 23.7×; 10y median 27.2×
Forward PE: 17.6×; 10y median 21.9×
Price to sales: 3.3×
EV/EBIT: 18.2×
Revenue, 12 months: $28.5B; +8% on a year ago
Net margin: 14.2%
Free cash flow yield: 4.4%

Marsh & McLennan Companies trades at 23.7× trailing earnings, cheaper than 75% of the last ten years. Revenue was $28.5B over the last twelve months, up 8% on a year earlier with a 14% net margin.

Charts

Financials

Income statement for MRSH, by quarter
Income statement	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26
	$5.6B+11%	$6.5B+9%	$6.2B+6%	$5.7B+6%	$6.1B+9%	$7.1B+9%	$7B+12%	$6.4B+12%	$6.6B+9%	$7.6B+8%	$7.4B+6%	$6.9B+8%
	$1.1B+62%	$1.9B+12%	$1.6B+13%	$1.1B+11%	$1.1B+4%	$2B+4%	$1.8B+11%	$1.2B+6%	$1.2B+7%	$1.8B−13%	$1.9B+4%	$1.2B+4%
Interest expense	$151M+19%	$159M+17%	$156M+7%	$154M+6%	$231M+53%	$245M+54%	$243M+56%	$237M+54%	$235M+2%	$240M−2%	$250M+3%	$248M+5%
Pre-tax income	$1B+71%	$1.9B+12%	$1.6B+13%	$1B+11%	$1B−4%	$1.8B−2%	$1.6B+5%	$1B−2%	$1.1B+5%	$1.6B−14%	$1.7B+3%	$1B+2%
	$283M+99%	$447M+9%	$425M+26%	$283M+47%	$208M−27%	$415M−7%	$415M−2%	$253M−11%	$222M+7%	$395M−5%	$411M−1%	$221M−13%
Net income	$756M+62%	$1.4B+13%	$1.1B+9%	$747M+2%	$788M+4%	$1.4B−1%	$1.2B+8%	$747M+0%	$821M+4%	$1.1B−17%	$1.3B+5%	$808M+8%
	$1.52+63%	$2.82+14%	$2.27+10%	$1.51+3%	$1.59+5%	$2.79−1%	$2.45+8%	$1.51+0%	$1.67+5%	$2.36−15%	$2.63+7%	$1.69+12%
	499M−1%	497M−1%	496M−1%	496M−1%	496M−1%	495M−0%	495M−0%	494M−0%	491M−1%	486M−2%	482M−3%	479M−3%

EPS, diluted: 11 periods, Q4 FY08 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 18 periods, Q4 FY08 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Estimates

Next earnings report: Feb 4, 2027.

Quarter	Revenue	Range	EPS	Range	Analysts
Q4 FY26	$6.9B	$6.8B to $7B	$2.22	$2.14 to $2.30	15
Q1 FY27	$8B	$7.9B to $8.1B	$3.57	$3.47 to $3.70	13
Q2 FY27	$7.8B	$7.7B to $7.9B	$3.22	$3.17 to $3.30	5
Q3 FY27	$7.1B	$7.1B to $7.3B	$2.22	$2.19 to $2.28	5
Q4 FY27	$7.3B	$7.2B to $7.4B	$2.45	$2.41 to $2.50	5
Q1 FY28	$8.4B	$8.3B to $8.6B	$3.91	$3.85 to $4.00	6
Q2 FY28	$8.3B	$8.2B to $8.4B	$3.57	$3.52 to $3.65	6
Q3 FY28	$7.6B	$7.5B to $7.7B	$2.47	$2.43 to $2.53	6

Peers

Companies in Insurance - Brokers nearest Marsh & McLennan Companies' size, closest first.

Company	Market cap	PE	Its 10y median PE	Fwd PE	P/S	Revenue growth	Net margin
MRSHMarsh & McLennan Companies	$93.9B	23.7×	27.2×	17.6×	3.3×	+8%	14.2%
AJGArthur J. Gallagher	$68.7B	44.5×	33.5×	19.2×	4.4×	+26%	10.0%
AONAon	$64.4B	16.7×	27.9×	15.8×	3.7×	+5%	22.3%
WTWWillis Towers Watson Public	$30.2B	19.9×	26.0×	15.5×	3.0×	+3%	15.5%
BROBrown & Brown	$24.4B	21.8×	29.1×	15.7×	3.6×	+34%	17.7%
ERIEErie Indemnity	$13.3B	23.0×	31.6×	n/m	3.2×	+4%	14.0%
RYANRyan Specialty	$11.2B	60.7×	92.3×	n/m	3.5×	+14%	3.1%
Peer median	$27.3B	22.4×	30.4×	15.8×	3.5×	+10%	14.7%